Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Urogynecology (Phila) ; 30(3): 309-313, 2024 03 01.
Artículo en Inglés | MEDLINE | ID: mdl-38484247

RESUMEN

ABSTRACT: Concurrent cervical cancer with advanced pelvic organ prolapse is rare: there are no well-established treatment recommendations. It is hypothesized that chronic irritation, as with long-standing pelvic organ prolapse, may lead to dysplasia and human papillomavirus-independent carcinoma, which represents only 5% of cervical cancers. Two patients with complete uterine procidentia were referred to gynecologic oncology with cervical squamous cell carcinoma; both were clinically staged as International Federation of Gynaecology and Obstetrics IB3. Treatment planning was complicated by procidentia in both cases. Standard definitive treatment of locally advanced cervical cancer is radiation therapy and concurrent chemotherapy; however, the mobility and externalization of the target lesion raised concerns regarding anatomic reproducibility during radiation treatment. After multidisciplinary team discussion (gynecologic oncology, urogynecology, radiation oncology), surgical resection and co-management with gynecologic oncology and urogynecology were successfully performed for definitive management for both patients. Although rare, this case study demonstrates the importance of multidisciplinary coordination in these complex clinical scenarios.


Asunto(s)
Carcinoma de Células Escamosas , Neoplasias de los Genitales Femeninos , Prolapso de Órgano Pélvico , Neoplasias del Cuello Uterino , Humanos , Femenino , Neoplasias del Cuello Uterino/complicaciones , Cisplatino , Carcinoma de Células Escamosas/complicaciones , Neoplasias de los Genitales Femeninos/tratamiento farmacológico , Reproducibilidad de los Resultados , Prolapso de Órgano Pélvico/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...